NCT04623801View on ClinicalTrials.gov

Laser Ablation of Papillary Thyroid Microcarcinoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Papillary Thyroid MicrocarcinomaThyroidThyroid Cancer
Interventions
PROCEDURE

Percutaneous Laser Ablation (PLA)

Percutaneous Laser Ablation / PLA will be carried out in a single session by advancing one 21-gauge spinal needle into the target lesions under real time US guidance.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER